Creating a Medical and Research Database for HGPS
为 HGPS 创建医学和研究数据库
基本信息
- 批准号:6596647
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-06-01 至 2005-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The Progeria Research Foundation(PRF) will establish an International Hutchinson-Gilford Progeria Syndrome (HGPS) Medical and Research Database for the purpose of obtaining long-term detailed clinical epidemiological and laboratory data on children with HGPS. HGPS is a rare and uniformly fatal "premature aging syndrome" in which children die of atherosclerotic heart disease at an average age of 13 years. Presently there is little clinical information available on children with HGPS. PRF is the only organization solely dedicated to medical research on HGPS. PRF is collaborating with the Brown University Center for Gerontology and Health Care Research, a well-established data and research center, in designing the database and the data collection protocol. With input and review by an expert scientific advisory committee, the Center's clinical nurse specialists, who have expertise in medical record abstraction, will implement this protocol for the records obtained in the project. The Engelhorn Foundation for Rare Diseases (EFFORD), a non-profit organization, will serve as the database repository. Data analysis will commence when records have been abstracted and data have been coded for 10 children. Results of analyses and other feedback will be provided to families, physicians and researchers through the PRF and EFFORD websites, information sheets, and publications. The proposed database will assist health care professionals in providing appropriate care for children with HGPS and will provide a better understanding of the variations in phenotype of HGPS. This project will make it possible to compile comprehensive in-depth data on the children with this rare disorder, which will serve as a valuable tool in understanding the basis of this disease, and in turn may lead to improvements in its diagnosis and treatment. It will provide a resource for new research in HGPS and in the aging diseases associated with HGPS such as atherosclerosis.
描述(由申请人提供):早衰症研究基金会(PRF)将建立一个国际哈钦森-吉尔福德早衰症(HGPS)医学和研究数据库,以获得HGPS儿童的长期详细临床流行病学和实验室数据。HGPS是一种罕见且一致致命的“早衰综合征”,其中儿童死于动脉粥样硬化性心脏病,平均年龄为13岁。目前,关于HGPS儿童的临床信息很少。PRF是唯一一个专门致力于HGPS医学研究的组织。PRF正在与布朗大学老年学和保健研究中心合作,这是一个完善的数据和研究中心,设计数据库和数据收集协议。在专家科学咨询委员会的输入和审查下,中心的临床护理专家(具有病历摘要方面的专业知识)将对项目中获得的记录实施本方案。Engelhorn罕见疾病基金会(EFFORD)是一个非营利组织,将作为数据库存储库。在提取记录并对10名儿童的数据进行编码后,将开始数据分析。分析结果和其他反馈将通过PRF和EFFORD网站、信息表和出版物提供给家庭、医生和研究人员。拟议的数据库将有助于卫生保健专业人员为HGPS儿童提供适当的护理,并将更好地了解HGPS表型的变化。该项目将能够汇编关于患有这种罕见疾病的儿童的全面深入的数据,这将成为了解这种疾病的基础的宝贵工具,从而可能导致其诊断和治疗的改进。它将为HGPS和与HGPS相关的衰老疾病(如动脉粥样硬化)的新研究提供资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LESLIE B GORDON其他文献
LESLIE B GORDON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LESLIE B GORDON', 18)}}的其他基金
The Progeria Research Foundation 8th International Scientific Workshop "Across the Table, Around the Globe"
早衰研究基金会第八届国际科学研讨会“跨越桌子,环游全球”
- 批准号:
9195040 - 财政年份:2016
- 资助金额:
$ 10万 - 项目类别:
PRF 11th Anniversary Workshop on Progeria - "Hand in Hand: Basic and Clinica
PRF 11 周年早衰症研讨会 - “手拉手:基础与临床
- 批准号:
8530081 - 财政年份:2013
- 资助金额:
$ 10万 - 项目类别:
PRF 10th Anniversary Workshop on Progeria - "From Bench to Bedside in a Decade"
PRF 10 周年早衰症研讨会 - “十年内从实验室到临床”
- 批准号:
7925396 - 财政年份:2010
- 资助金额:
$ 10万 - 项目类别:
The 2007 Progeria Research Foundation Workshop on Hutchinson Gilford Progeria
2007 年早衰症研究基金会哈钦森·吉尔福德早衰症研讨会
- 批准号:
7407834 - 财政年份:2007
- 资助金额:
$ 10万 - 项目类别:
The Progeria Research Foundation International Progeria Workshop
早衰症研究基金会国际早衰症研讨会
- 批准号:
7128295 - 财政年份:2006
- 资助金额:
$ 10万 - 项目类别:
Creating a Medical and Research Database for HGPS
为 HGPS 创建医学和研究数据库
- 批准号:
6752067 - 财政年份:2003
- 资助金额:
$ 10万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Studentship
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
- 批准号:
10589484 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:














{{item.name}}会员




